Genome-wide CRISPR screens identify CLC-2 as a drug target for anti-herpesvirus therapy: tackling herpesvirus drug resistance.
Yang F, Wei N, Cai S, Liu J, Lan Q, Zhang H, Shang L, Zheng B, Wang M, Liu Y, Zhang L, Fei C, Tong W, Liu C, Kuang E, Tong G, Gu F.
Yang F, et al.
Sci China Life Sci. 2025 Feb;68(2):515-526. doi: 10.1007/s11427-023-2627-8. Epub 2024 Oct 12.
Sci China Life Sci. 2025.
PMID: 39428427
The results demonstrated that type 2 voltage-gated chloride channels (CLC-2) encoded by one of the identified genes, CLCN2, is a potential drug target for anti-herpesvirus therapy. ...The study's findings suggest that targeting host-cell factors such as CL …
The results demonstrated that type 2 voltage-gated chloride channels (CLC-2) encoded by one of the identified genes, CLCN2 …